1.
Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI,
T O'Brien J, Barkhof F, Benavente OR: Neuroimaging standards for research into small vessel disease and its contribution
to ageing and neurodegeneration. The Lancet Neurology 2013, 12(8):822-838.
2.
Kim BJ, Lee S-H: Prognostic impact of cerebral small vessel disease on stroke outcome. Journal of stroke 2015, 17(2):101.
3.
Weimar C, Kurth T, Kraywinkel K, Wagner M, Busse O, Haberl RL, Diener H-C: Assessment of functioning and disability after ischemic stroke. Stroke 2002, 33(8):2053-2059.
4.
Inoue K, Matsumoto M, Shono T, Toyokawa S, Moriki A: Increased intima media thickness and atherosclerotic plaques in the carotid artery
as risk factors for silent brain infarcts. Journal of Stroke and Cerebrovascular Diseases 2007, 16(1):14-20.
5.
Hassan A, Hunt BJ, O’sullivan M, Parmar K, Bamford JM, Briley D, Brown MM, Thomas
DJ, Markus HS: Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain 2003, 126(2):424-432.
6.
Wardlaw J: Blood-brain barrier and cerebral small vessel disease. Journal of the neurological sciences 2010, 299(1-2):66-71.
7.
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J,
Brown M, Demaerschalk BM, Hoh B: 2018 guidelines for the early management of patients with acute ischemic stroke: a
guideline for healthcare professionals from the American Heart Association/American
Stroke Association. Stroke 2018, 49(3):e46-e110.
8.
Bang O, Saver J, Liebeskind D, Pineda S, Ovbiagele B: Association of serum lipid indices with large artery atherosclerotic stroke. Neurology 2008, 70(11):841-847.
9.
Luz PLd, Favarato D, Faria-Neto Junior JR, Lemos P, Chagas ACP: High ratio of triglycerides to HDL-cholesterol predicts extensive coronary disease. Clinics 2008, 63(4):427-432.
10.
Boizel R, Benhamou PY, Lardy B, Laporte F, Foulon T, Halimi S: Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in
patients with type 2 diabetes and normal HDL cholesterol levels. Diabetes care 2000, 23(11):1679-1685.
11.
Cabrera MAS, de Andrade SM, Mesas AE: A prospective study of risk factors for cardiovascular events among the elderly. Clinical interventions in aging 2012, 7:463.
12.
Frohlich J, Dobiášová M: Fractional esterification rate of cholesterol and ratio of triglycerides to HDL-cholesterol
are powerful predictors of positive findings on coronary angiography. Clinical chemistry 2003, 49(11):1873-1880.
13.
Yoshida A, Kouwaki M, Matsutani Y, Fukuchi Y, Naito M: Usefulness of serum total cholesterol/triglyceride ratio for predicting the presence
of small, dense LDL. Journal of atherosclerosis and thrombosis 2004, 11(4):215-219.
14.
Urbina EM, Khoury PR, McCoy CE, Dolan LM, Daniels SR, Kimball TR: Triglyceride to HDL-C ratio and increased arterial stiffness in children, adolescents,
and young adults. Pediatrics 2013:peds. 2012-1726.
15.
Bhalodkar NC, Blum S, Enas EA: Accuracy of the ratio of triglycerides to high-density lipoprotein cholesterol for
predicting low-density lipoprotein cholesterol particle sizes, phenotype B, and particle
concentrations among Asian Indians. The American journal of cardiology 2006, 97(7):1007-1009.
16.
Dobiás̆ová M, Frohlich J: The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein
particle size and esterification rate inapob-lipoprotein-depleted plasma (FERHDL). Clinical biochemistry 2001, 34(7):583-588.
17.
Pacifico L, Bonci E, Andreoli G, Romaggioli S, Di Miscio R, Lombardo C, Chiesa C:
Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media
thickness, insulin resistance and nonalcoholic fatty liver disease in children and
adolescents. Nutrition, Metabolism and Cardiovascular Diseases 2014, 24(7):737-743.
18.
Salazar MR, Carbajal HA, Espeche WG, Aizpurúa M, Maciel PM, Reaven GM: Identification of cardiometabolic risk: visceral adiposity index versus triglyceride/HDL
cholesterol ratio. The American journal of medicine 2014, 127(2):152-157.
19.
Hermans MP, Ahn SA, Rousseau MF: The atherogenic dyslipidemia ratio [log (TG)/HDL-C] is associated with residual vascular
risk, beta-cell function loss and microangiopathy in type 2 diabetes females. Lipids in health and disease 2012, 11(1):132.
20.
Lamarche B, Després J-P, Moorjani S, Cantin B, Dagenais GR, Lupien P-J: Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results
from the Quebec cardiovascular study. Atherosclerosis 1996, 119(2):235-245.
21.
Deng QW, Wang H, Sun CZ, Xing FL, Zhang HQ, Zuo L, Gu ZT, Yan FL: Triglyceride to high‐density lipoprotein cholesterol ratio predicts worse outcomes
after acute ischaemic stroke. European journal of neurology 2017, 24(2):283-291.
22.
Nam K-W, Kwon H-M, Jeong H-Y, Park J-H, Kim SH, Jeong S-M, Yoo TG, Kim S: Cerebral white matter hyperintensity is associated with intracranial atherosclerosis
in a healthy population. Atherosclerosis 2017, 265:179-183.
23.
Chimowitz M, Lynn M, Howlett-Smith H, Stern B, Hertzberg V, Frankel M, Chaturvedi
S, Kasner S, Benesch C, Sila C: Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Trial: final results. In: Stroke: 2004: LIPPINCOTT WILLIAMS & WILKINS 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA; 2004:
235-235.
24.
O'meara JG, Kardia SL, Armon JJ, Brown CA, Boerwinkle E, Turner ST: Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia
among hypertensive adults in the GENOA study. Archives of internal medicine 2004, 164(12):1313-1318.
25.
Bittner V, Johnson BD, Zineh I, Rogers WJ, Vido D, Marroquin OC, Bairey-Merz CN, Sopko
G: The TG/HDL cholesterol ratio predicts all cause mortality in women with suspected
myocardial ischemia a report from the Women’s Ischemia Syndrome Evaluation (WISE). American heart journal 2009, 157(3):548.
26.
Mazza A, Tikhonoff V, Schiavon L, Casiglia E: Triglycerides+ high‐density‐lipoprotein‐cholesterol dyslipidaemia, a coronary risk
factor in elderly women: the CArdiovascular STudy in the ELderly. Internal medicine journal 2005, 35(10):604-610.
27.
Freiberg JJ, Tybjærg-Hansen A, Jensen JS, Nordestgaard BG: Nonfasting triglycerides and risk of ischemic stroke in the general population. Jama 2008, 300(18):2142-2152.
28.
Varbo A, Nordestgaard BG, Tybjærg‐Hansen A, Schnohr P, Jensen GB, Benn M: Nonfasting triglycerides, cholesterol, and ischemic stroke in the general population. Annals of neurology 2011, 69(4):628-634.
29.
Masson W, Siniawski D, Lobo M, Molinero G, Huerín M: Association between triglyceride/HDL cholesterol ratio and carotid atherosclerosis
in postmenopausal middle-aged women. Endocrinología y Nutrición (English Edition) 2016, 63(7):327-332.
30.
Masley SC, Roetzheim R, Masley LV, McNamara T, Schocken DD: Emerging risk factors as markers for carotid intima media thickness scores. Journal of the American College of Nutrition 2015, 34(2):100-107.
31.
Shishehbor MH, Hoogwerf BJ, Lauer MS: Association of triglyceride–to–HDL cholesterol ratio with heart rate recovery. Diabetes Care 2004, 27(4):936-941.
32.
González-Chávez A, Simental-Mendía LE, Elizondo-Argueta S: Elevated triglycerides/HDL-cholesterol ratio associated with insulin resistance. Cir Cir 2011, 79(2):126-131.
33.
Lee JE, Shin DW, Yun JM, Kim SH, Nam Y-S, Cho B, Lim J-S, Jeong H-Y, Kwon H-M, Park
J-H: Insulin resistance is a risk factor for silent Lacunar infarction. Stroke 2016:STROKEAHA. 116.014097.
34.
Golan R, Shelef I, Rudich A, Gepner Y, Shemesh E, Chassidim Y, Harman-Boehm I, Henkin
Y, Schwarzfuchs D, Avraham SB: Abdominal superficial subcutaneous fat: a putative distinct protective fat subdepot
in type 2 diabetes. Diabetes care 2012:DC_111583.